InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
86.58
(
-0.39%
)
Bitcoin
58,787.11
(
-2.29%
)
Post# of 252478
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 832
Posts 119978
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 209242

Thursday, 02/23/2017 11:11:22 AM

Thursday, February 23, 2017 11:11:22 AM

Post# of 252478
ICPT -8% on 4Q16 results:

http://finance.yahoo.com/news/intercept-pharmaceuticals-reports-full-2016-120500011.html

Perhaps the reason for the sell-off is that today’s PR makes no attempt to clarify the ambiguous discussion about the REGENERATE protocol changes on the 2/10/17 CC (#msg-128849931).

There are still some investors who are convinced that ICPT merely needs to show p<0.05 on either of the co-primary endpoints in the interim analysis for the trial to be deemed a success for FDA accelerated approval.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up